Human Rabies Immunoglobulin (300IU)
Berirab P Injection is given as an injection by a doctor or nurse. It must always be used in combination with a rabies vaccine. Post-exposure prophylaxis consists of a regimen of one dose of immunoglobulin and full courses of rabies vaccination. This should be given as soon as possible after exposure. Both active (vaccine) and passive immunization (Immunoglobulin) prevent the rabies virus from infiltrating the central nervous system, but become ineffective once the virus has crossed into the central nervous system. Berirab P Injection is administered only once in a lifetime.The most common side effects include pain, anaphylactic reaction, angioedema (swelling of deeper layers of skin), injection site stiffness, soreness, and tenderness. They do not normally last very long. Sitting or lying down can sometimes help. Consult your doctor if any of the side effects persist or worry you.Before having the injection, you should tell your doctor if you’ve ever had an allergic reaction to an immunoglobulin. Some other medicines may react with the human rabies immunoglobulin so talk to your doctor about other medications you are taking as well. You should consult your doctor first if you are pregnant or breastfeeding.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Berirab P
2 ml Injection
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Berirab P Injection works by giving your body the antibodies it needs to protect it against the rabies virus. This is called passive protection.
Related Warnings
It is not known whether it is safe to consume alcohol with Berirab P Injection. Please consult your doctor.
Berirab P Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Berirab P Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Berirab P Injection does not usually affect your ability to drive.
Berirab P Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Berirab P Injection may not be needed in these patients. Please consult your doctor.
Berirab P Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Berirab P Injection may not be needed in these patients. Please consult your doctor.
Berirab P Injection is a solution containing a large amount of rabies antibodies. It is used to provide protection against rabies. It is given either along with the first dose of anti-rabies vaccine(ARV) or not more than 7 days later.
Rabies is a 100% preventable disease. Proper wound management and simultaneous administration of Berirab P Injection combined with anti-rabies vaccine (ARV) is almost invariably effective in preventing rabies, even after high-risk exposure.
Berirab P Injection is not required for patients who have previously received a complete vaccination series of rabies.
Whether Berirab P Injection is painful or not depends on your pain tolerance. During your initial treatment, a healthcare professional will put Berirab P Injection in the area where you were bitten. This can be painful. Therefore, a relatively greater amount of Berirab P Injection may be required to be placed in and around the wound site to ease out your pain and treat infection.
Equine Rabies Immunoglobulin is more economical as compared to Berirab P Injection i.e., human rabies immunoglobulin (HRIG). Hence, it is more affordable to patients in developing countries, like India. However, Equine Rabies Immunoglobulin has a high potential to cause anaphylaxis (a severe, potentially life-threatening allergic reaction), serum sickness and other allergic reactions and thus physicians are hesitant to use it.
Berirab P Injection is a solution containing a large amount of rabies antibodies. It is used to provide protection against rabies. It is given either along with the first dose of anti-rabies vaccine(ARV) or not more than 7 days later.
Rabies is a 100% preventable disease. Proper wound management and simultaneous administration of Berirab P Injection combined with anti-rabies vaccine (ARV) is almost invariably effective in preventing rabies, even after high-risk exposure.
Berirab P Injection is not required for patients who have previously received a complete vaccination series of rabies.
Whether Berirab P Injection is painful or not depends on your pain tolerance. During your initial treatment, a healthcare professional will put Berirab P Injection in the area where you were bitten. This can be painful. Therefore, a relatively greater amount of Berirab P Injection may be required to be placed in and around the wound site to ease out your pain and treat infection.
Equine Rabies Immunoglobulin is more economical as compared to Berirab P Injection i.e., human rabies immunoglobulin (HRIG). Hence, it is more affordable to patients in developing countries, like India. However, Equine Rabies Immunoglobulin has a high potential to cause anaphylaxis (a severe, potentially life-threatening allergic reaction), serum sickness and other allergic reactions and thus physicians are hesitant to use it.
